$TRNS

Dominach Oksana S. sold $626K of TRNS

Dominach Oksana S. sold 7,312 shares of TRANSCAT INC (TRNS) at $85.60 ($0.63M total) on 2026-09-02.

Original reporting
SEC EDGAR · Dominach Oksana S.
Published Sep 3, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 7:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRNS
Neutral
medium confidence
Mentioned
$TRNS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRNSNeutralLow
01

Why it matters

The director's sale is modest and unlikely to move the stock materially.

02

Market read

Limited relevance; primarily of interest to existing shareholders and insiders.

03

What to watch

Potential upcoming corporate actions or personal liquidity needs are not disclosed.

Relevance 5/10Novelty 5/10Timing: filed today

Background

Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

$TRNSNeutralMedium confidence
Context

Director Oksana Dominach sold 7,312 shares of Transcat Inc for $625,876, reducing her stake to 4,346 shares.

Expected impact

Minor downward pressure, likely within normal trading range.

Evidence & confidence

Sale size is small relative to market cap and no broader context indicates distress.

Market effects

None significant for the industrial equipment sector.

No regional effect.

Limited to Transcat shareholders.

Counterpoint

The sale could be a routine portfolio rebalancing, not a signal of underlying weakness.

Key entities

  • Transcat Inc

    Publicly traded industrial equipment manufacturer (ticker TRNS).

  • Oksana S. Dominach

    Director of Transcat Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRNSMed

Transcat’s (NASDAQ:TRNS) Q2 CY2026: Strong Sales

Transcat (NASDAQ:TRNS) reported Q2 CY2026 results. Revenue rose 21.6% year on year to $92.95 million, topping Wall Street estimates by 7.4%. Non-GAAP adjusted EPS was $0.51, up 35.1% versus analysts’ consensus and down from $0.59 a year earlier. Analysts expect revenue to grow about 6% over the next 12 months.

$TRNSMed

TRANSCAT INC (TRNS): Results of Operations and Financial Condition

TRANSCAT INC (TRNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE Transcat, Inc. 35 Vantage Point Drive • Rochester • NY • 14624 • Phone: (585) 352-7777 Transcat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Service Gross Margin Expansion • Q1’27 Revenu

$TRNSHighAI 9/10

Transcat Inc (TRNS) Q4 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion

Transcat’s CEO Jaime Irick said he will apply Lean Six Sigma to improve efficiency, cycle times, customer-facing processes, and innovation. CFO Thomas Barbato noted Q4 service gross margins were pressured by new customer onboarding, expecting normalization in fiscal 2027 H1 and year-over-year margin gains for the full year. He reiterated an M&A push into new geographies, citing a Latin America SCM acquisition in Costa Rica and exploring sites in several US regions; rental is expected to grow low

$TRNSHighAI 9/10

Transcat Q4 Earnings Call Highlights

Transcat (NASDAQ:TRNS) reported fiscal Q4 consolidated revenue up 16% to $89.3M and full-year revenue up 19% to $331.9M, according to management on its earnings call. Service revenue rose 18% (7% organic) and marked 68 straight quarters of YoY service growth; service gross margin was 35.5%. Adjusted Q4 EPS was $0.56; full-year adjusted EPS $1.84. Management expects higher service organic growth in fiscal Q1 vs Q4.

$TRNSHighAI 9/10

Full Transcript: Transcat Q4 2026 Earnings Call - Transcat (NASDAQ: TRNS)

Transcat (NASDAQ:TRNS) reported Q4 FY2026 consolidated revenue of $89.3 million, up 16%, and full-year revenue growth of 19%. Service revenue rose 18% in Q4 and 20% for the year, supporting gross profit up 18% and gross margin expansion of 50 bps. Adjusted EBITDA grew 23% for the full year. The company said its SCM Metrology acquisition expands operations into Latin America.